BMC Genomic Data publishes a range of articles that describe genomic datasets and genomic analyses. These are peer reviewed by experts in the field. We welcome articles that include analyses or meta-analyses of existing data, and original articles on databases or other technologies that advance data sharing and reuse to support reproducible research. As a supporter of the FAIR Data principles, release of data in one or more public, community-recognized repositories is a condition of publication.
Aims and scope
Why publish your article in BMC Genomic Data?
- We welcome data-focused articles across the entire field of genomics and genetics.
- As the OA market leader in genetics and genomics, BMC has a long-standing reputation as a pioneer of open science in the field.
- High-quality journal with rigorous peer review, supported by an international editorial board chosen for their expertise in genomic data and commitment to open science.
- Supports the FAIR Data principles
- Offers authors more ways to publish data-focussed or data-only articles, with an emphasis on the FAIR sharing of data over the novelty of results
- Draws on Springer Nature’s Research Data expertise to make it easy for authors to follow best practice in data sharing
All articles published by BMC Genomic Data are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in BMC Genomic Data you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. BMC Genomic Data therefore levies an article-processing charge of £1110.00/$1650.00/€1330.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
For more information on APCs please see our Journal Pricing FAQs
All articles published in BMC Genomic Data are included in:
- Biological Abstracts
- Global Health
- PubMed Central
- Science Citation Index Expanded
- Zoological Record
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
BMC Genomic Data operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Manuscripts submitted to BMC Genomic Data are assessed by our editors and/or peer reviewers. Overall editorial responsibility for the journal is with the Editor, with Editorial Board Members acting as handling editors.
BMC Genomic Data is part of the BMC Series which publishes subject-specific journals focused on the needs of individual research communities across all scientific and clinical disciplines. We do not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field.
Specific criteria for other article types can be found in the submission guidelines.
All manuscripts submitted to BMC Genomic Data should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.
Citing articles in BMC Genomic Data
Articles in BMC Genomic Data should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. BMC Genom Data [year], [volume number]:[article number].
Benefits of publishing with BMC
BMC Genomic Data's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
BMC Genomic Data offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in BMC Genomic Data gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in BMC Genomic Data are included in article alerts and regular email updates. Some may be highlighted on BMC Genomic Data’s pages and on the BMC homepage.
In addition, articles published in BMC Genomic Data may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in BMC Genomic Data. A list of articles recently press-released by journals published by BMC is available here.
As an author of an article published in BMC Genomic Data you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
For further information about the advantages of publishing in a journal from BMC, please click here.
Annual Journal Metrics
For BMC Genetics (former title)
108 days to first decision for reviewed manuscripts only
62 days to first decision for all manuscripts
190 days from submission to acceptance
22 days from acceptance to publication
429 Altmetric mentions
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.